Clinical Trials Browser

Phase 2/3 × Critical Illness × Genitourinary × Clear all

NCT02531412 2017-01-04

SPIROCAN

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

Phase 2/3 Terminated

Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness